Capitolis Advisors LLC Abbott Laboratories Transaction History

Capitolis Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $56.2 Million - $68.6 Million	-493,028 Reduced 76.77%	149,167 $17.7 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $5.69 Million - $6.96 Million	49,215 Added 8.3%	642,195 $90.4 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $6.62 Million - $7.33 Million	-56,781 Reduced 8.74%	592,980 $69.3 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $65.8 Million - $77.4 Million	621,921 Added 2233.91%	649,761 $75.3 Million
Q4 2020 May 07, 2021	BUY	$105.0 - $114.42 $2.92 Million - $3.19 Million	27,840 New	27,840 $3.05 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.